Clues to building a better herpes vaccine

vaccine
Credit: CC0 Public Domain

Efforts to develop an effective vaccine for genital herpes, a common sexually transmitted disease, have largely failed. In a new study published in Nature, Yale researchers explore why, and their findings could lead to a better vaccine.

Senior investigator Akiko Iwasaki and her colleagues conducted several experiments in mice vaccinated against the 2 (HSV-2). The researchers first found that the HSV-2 antibody the body produces in response to vaccination was not present in the vaginal cavity where it is most needed to protect against infection. They also learned that when specialized , called memory B cells, are physically drawn to the genital area, they produce and insert the antibody in the inner vaginal tissue. Having the antibody circulating in the blood alone is not enough to protect against infection, and a different strategy is needed to deliver the protective antibody in the future, Iwasaki said.

These results may explain why herpes vaccines that have been developed to date have not worked, say the researchers. The findings also support a different approach to vaccination, such as "prime and pull," which Iwasaki's lab has been investigating. This strategy involves combining conventional vaccination to trigger an immune response throughout the body (prime) and "chemokines," or signaling proteins, in vaginal tissue to attract another immune cell type, memory T cells, to the site where infection happens (pull). The team is currently working on establishing a successful prime-and-pull vaccine based on T cells and B cells.


Explore further

New findings could lead to improved vaccinations against sexually transmitted infections

More information: Ji Eun Oh et al. Migrant memory B cells secrete luminal antibody in the vagina, Nature (2019). DOI: 10.1038/s41586-019-1285-1
Journal information: Nature

Provided by Yale University
Citation: Clues to building a better herpes vaccine (2019, June 13) retrieved 24 June 2019 from https://medicalxpress.com/news/2019-06-clues-herpes-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
66 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more